BiotechTube
Home/EydisBio/Dr. Philip Hughes, PhD
DP

Dr. Philip Hughes, PhD

Executive Vice President of Chemistry

EydisBio

Therapeutic Areas

Autoimmune DiseasesInflammatory DiseasesChronic PainFibrotic Diseases

EydisBio Pipeline

DrugIndicationPhase
EYD-001 (Takinib analog)Rheumatoid ArthritisPreclinical
Pipeline of small moleculesAutoimmune/Inflammatory Diseases & Immune-related CancersDiscovery

Leadership Team at EydisBio

DT
Dr. Timothy Haystead, PhD
President & Founder
DS
Dr. Scott Scarneo, MBA, PhD
Chief Scientific Officer
View full EydisBio profile